These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38964549)

  • 1. Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.
    Tersalvi G; Bossard M; Aeschbacher S; Wiencierz A; Beer JH; Rodondi N; Gencer BF; Reichlin T; Auricchio A; Ammann P; Moschovitis G; Bonati L; Osswald S; Kühne M; Conen D; Kobza R
    Int J Cardiol; 2024 Oct; 412():132320. PubMed ID: 38964549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes.
    Younis A; Tabaja C; Santangeli P; Nakagawa H; Sipko J; Madden R; Bouscher P; Taigen T; Higuchi K; Hayashi K; El Hajjar AH; Chamseddine F; Callahan T; Martin DO; Nakhla S; Kanj M; Sroubek J; Lee JZ; Saliba WI; Wazni OM; Hussein AA
    Circ Arrhythm Electrophysiol; 2024 Sep; 17(9):e012926. PubMed ID: 39193716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O;
    Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Prognostic Implication of Atrial Fibrillation in Heart Failure Subtypes: Systematic Review and Meta-Analysis.
    Mundisugih J; Franke KB; Tully PJ; Munawar DA; Kumar S; Mahajan R
    Heart Lung Circ; 2023 Jun; 32(6):666-677. PubMed ID: 37003940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction.
    Schupp T; Schmitt A; Reinhardt M; Abel N; Lau F; Abumayyaleh M; Dudda J; Weidner K; Ayoub M; Akin M; Müller J; Akin I; Behnes M
    Eur J Prev Cardiol; 2024 Aug; 31(11):1372-1384. PubMed ID: 38825871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of left atrial appendage closure in atrial fibrillation patients with different types of heart failure.
    Liu L; Yan W; Xu X; Wan C; Liu F; Yao Q; Song L; Wang B; Song Z; Li H
    BMC Cardiovasc Disord; 2024 Aug; 24(1):430. PubMed ID: 39148039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between atrial fibrillation and heart failure with different ejection fraction categories and its influence on outcomes.
    Xu HX; Zhu YM; Hua Y; Huang YH; Lu Q
    Acta Cardiol; 2020 Sep; 75(5):423-432. PubMed ID: 31141463
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic Significance of New-Onset Atrial Fibrillation in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Following Acute Myocardial Infarction: Data from the NOAFCAMI-SH Registry.
    Hao C; Luo J; Liu B; Xu W; Li Z; Gong M; Qin X; Shi B; Wei Y
    Clin Interv Aging; 2022; 17():479-493. PubMed ID: 35444413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both HFpEF and HFmrEF should be included in calculating CHA
    Cheng CC; Huang PS; Chen JJ; Chiu FC; Chang SN; Wang YC; Wu CK; Hwang JJ; Tsai CT
    Heart Rhythm; 2024 Sep; 21(9):1500-1506. PubMed ID: 38423377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Nicoli CD; O'Neal WT; Levitan EB; Singleton MJ; Judd SE; Howard G; Safford MM; Soliman EZ
    Heart; 2022 Mar; 108(5):353-359. PubMed ID: 34031160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.